Peter C Farrell Resmed Inc (RSMDF) insider trading activity

RSMDF Quotes by TradingView

Peter C Farrell is Director of RESMED INC. Currently has a direct ownership of 81,218 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Dec 04, 2024, when has been sold 2,000 shares (ResMed Common Stock) at a price of $245.65 per share, resulting in proceeds of $491,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81.2K
6.86% 3M change
55.11% 12M change
Total Value Held $0

PETER C FARRELL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 04 2024
SELL
Open market or private sale
$491,300 $245.65 p/Share
2,000 Reduced 2.4%
81,218 ResMed Common Stock
Nov 20 2024
BUY
Grant, award, or other acquisition
-
542 Added 0.65%
83,218 ResMed Common Stock
Nov 11 2024
SELL
Payment of exercise price or tax liability
$133,004 $252.38 p/Share
527 Reduced 0.63%
82,676 ResMed Common Stock
Nov 06 2024
SELL
Open market or private sale
$497,480 $248.74 p/Share
2,000 Reduced 2.35%
83,204 ResMed Common Stock
Oct 02 2024
SELL
Open market or private sale
$474,400 $237.2 p/Share
2,000 Reduced 2.29%
85,204 ResMed Common Stock
Sep 04 2024
SELL
Open market or private sale
$479,800 $239.9 p/Share
2,000 Reduced 2.24%
87,204 ResMed Common Stock
May 15 2024
SELL
Bona fide gift
-
68,200 Reduced 43.33%
89,204 ResMed Common Stock
Feb 22 2024
SELL
Open market or private sale
$1,997,387 $182.66 p/Share
10,935 Reduced 6.5%
157,404 ResMed Common Stock
Nov 16 2023
BUY
Grant, award, or other acquisition
-
1,768 Added 0.97%
180,939 ResMed Common Stock
Nov 13 2023
SELL
Payment of exercise price or tax liability
$46,670 $143.6 p/Share
325 Reduced 0.18%
179,171 ResMed Common Stock
May 03 2023
SELL
Open market or private sale
$2,988,342 $237.17 p/Share
12,600 Reduced 7.02%
166,896 ResMed Common Stock
Nov 16 2022
BUY
Grant, award, or other acquisition
-
1,122 Added 0.62%
179,496 ResMed Common Stock
Nov 11 2022
SELL
Payment of exercise price or tax liability
$28,823 $225.18 p/Share
128 Reduced 0.07%
178,374 ResMed Common Stock
Oct 31 2022
SELL
Open market or private sale
$2,008,919 $221.98 p/Share
9,050 Reduced 4.71%
183,052 ResMed Common Stock
Oct 31 2022
SELL
Bona fide gift
-
4,550 Reduced 2.49%
178,502 ResMed Common Stock
Nov 18 2021
BUY
Grant, award, or other acquisition
-
478 Added 0.25%
192,102 ResMed Common Stock
Nov 11 2021
SELL
Payment of exercise price or tax liability
$88,739 $259.47 p/Share
342 Reduced 0.18%
191,624 ResMed Common Stock
Aug 13 2021
SELL
Bona fide gift
-
36,670 Reduced 16.04%
191,966 ResMed Common Stock
Nov 19 2020
BUY
Grant, award, or other acquisition
-
1,187 Added 0.52%
228,636 ResMed Common Stock
Nov 11 2020
SELL
Payment of exercise price or tax liability
$122,812 $212.11 p/Share
579 Reduced 0.25%
227,449 ResMed Common Stock

Also insider at

EOLS
Evolus, Inc. Healthcare
Director
ARCT
Arcturus Therapeutics Holdings Inc. Healthcare
Director
PCF

Peter C Farrell

Director
Newport Beach, CA

Track Institutional and Insider Activities on RSMDF

Follow RESMED INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

News

Receive news related to RESMED INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RSMDF